Statistical methods in gastroenterology & hepatology trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
Cochran-Mantel-Haenszel test
Risk difference
ANCOVA
Non-inferiority trial design
Kaplan-Meier estimation
Time-to-event endpoints
Multiple imputation / missing data
Odds ratio
All gastroenterology & hepatology trials
2 results
- FEM-PrEPIndependent statistical analysis of FEM-PrEP, a randomized phase 3 trial evaluating Truvada versus placebo for preventing HIV acquisition in women, including its time-to-event analysis, safety endpoints, secondary outcomes, and statistical interpretation.
- iPrExIndependent statistical analysis of the randomized phase 3 iPrEx trial of daily TDF/FTC versus placebo for HIV prevention in men, including primary efficacy and safety endpoints, secondary analyses, statistical methods, and interpretation.